Home > BIGG > Search result

    Results: 3

    ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation

    Buse, Giovanna Lurati; Pinto, Bernardo Bollen; Abelha, Fernando; Abbott, Tom E. F; Ackland, Gareth; Afshari, Arash; De Hert, Stefan; Fellahi, Jean-Luc; Giossi, Laure; Kavsak, Peter; Longrois, Dan; M’Pembele, Rene; Nucaro, Anthony; Popova, Ekaterine; Puelacher, Christian; Richards, Toby; Roth, Sebastian; Sheka, Mootii; Szczeklik, Wojciech; van Waes, Judith; Walder, Bernhard; Chew, Michelle S.
    Eur. j. anaesthesiol; 40 (12), 2023
    In recent years, there has been increasing focus on the use of cardiac biomarkers in patients undergoing noncardiac surgery. The aim of this focused guideline was to provide updated guidance regarding the pre-, post- and combined pre-and postoperative use of cardiac troponin and B-type natriuretic peptid...
    Perioperative Medicine/standards, Biomarkers/analysis, Risk Evaluation and Mitigation, Heart Disease Risk Factors, Natriuretic Peptide, Brain
    Fulltext

    Guía de práctica clínica para el diagnóstico y tratamiento de la insuficiencia cardiaca congestiva

    Peru. Instituto de Evaluación de Tecnologías en Salud e Investigación.
    La insuficiencia cardíaca (IC) es un síndrome clínico caracterizado por la presencia de síntomas típicos (como disnea, hinchazón de tobillos y cansancio), que suelen acompañarse de signos (como estertores pulmonares, elevación de la presión venosa yugular y edema periférico), como consecuencia ...
    Heart Failure/diagnosis, Heart Failure/drug therapy, Natriuretic Peptide, Brain, Echocardiography, Adrenergic beta-Antagonists/therapeutic use
    Fulltext

    Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

    Dent, S; Brezden-Masley, C; Clarke, B; Davis, MK; Jassal, DS; Johnson, C; Lemieux, J; Paterson, I; Sebag, IA; Simmons, C; Sulpher, J; Thain, K; Thavendiranathan, P; Wentzell, JR; Wurtele, N; Côté, MA; Fine, NM; Haddad, H; Hayley, BD; Hopkins, S; Joy, AA; Rayson, D; Stadnick, E; Straatman, L; Virani, SA.
    Can. j. cardiol; 32 (7), 2016
    Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
    Antineoplastic Agents, Biomarkers, Cardiotonic Agents, Cardiotoxins, Troponin T, Natriuretic Peptide, Brain, C-Reactive Protein, Antineoplastic Agents/adverse effects, Arrhythmias, Cardiac, Cardiotoxicity, Coronary Thrombosis, Early Diagnosis, Echocardiography, Three-Dimensional, Hypertension/therapy, Magnetic Resonance Imaging, Cine, Myocardial Ischemia, Neoplasms/therapy, Primary Prevention, Radiotherapy, Risk Factors, Ventricular Dysfunction, Left, Cardiotoxicity/diagnosis, Cardiotoxins/adverse effects, Radiotherapy/adverse effects
    Fulltext